Medical devices are becoming increasingly sophisticated; as such, manufacturers face pressure to speed up innovation while tackling development, regulatory, and production requirements. Technology solutions for cardiovascular, neurovascular, and robotic surgery require tighter tolerances, specialized materials, and seamless collaboration across the product lifecycle.

As a result, medical device OEMs are leaning more on contract development and manufacturing organizations (CDMOs) to eliminate challenging supply chains and logistical concerns during the development and production process. Maintaining a partnership with a single entity that can aid with the full process, from material selection through to the final steps can enhance a product lifecycle’s timeline.

In the following Q&A, Dean Childers, Vice President and General Manager of DuPont Healthcare Solutions, offers insights on the importance of global manufacturing and technical support, the value of aligning development and production teams from the outset, and DuPont’s long-term vision for helping customers scale innovation while advancing patient care worldwide.

Sean Fenske: What are you hearing most from customers when it comes to what they need from a medical device CDMO today?

Dean Childers: The message is consistent wherever we go. Customers want to work with fewer, more capable suppliers, ideally one that can…